Active ingredients
Pharmacological Group
Analogs
Complete analogs for the substance
- 0.6€ ≈100% Interferon leukocytic human
- — ≈100% Interferon leukocytic human siccum
- — ≈100% Interferon leucocytic human concentrated fluid
- — ≈100% Locferon
- — ≈100% Alfaferone
- 96% — Wellferon [Interferon alfa and more 1Proteine]
- 96% 1.3€ Interferon leukocytic human fluid [Interferon alfa and more 1Proteine]
- 87% 39€ Realdiron [Interferon alfa-2b human recombinant and more 1Interferon alfa]
- 84% — Interferon alfa-2 ointment [Interferon alfa-2 and more 1Interferon alfa]
- Show all
Analogs by action
ATX code
L03AB01 Интерферон альфа.
Used in the treatment of
- N80 Endometriosis
- N71 Inflammatory disease of uterus, except cervix
- K73 Chronic hepatitis, not elsewhere classified
- G35 Multiple sclerosis
- D84.9 Immunodeficiency, unspecified
- C92.1 Chronic myeloid leukaemia [CML], BCR/ABL-positive
- C91.4 Hairy-cell leukaemia
- C84.0 Mycosis fungoides
- C83 Non-follicular lymphoma
- C64 Malignant neoplasm of kidney, except renal pelvis
- C44 Other malignant neoplasms of skin
- C43 Malignant melanoma of skin
- C20 Malignant neoplasm of rectum
- B37.2 Candidiasis of skin and nail
- B37 Candidiasis
- B21.0 HIV disease resulting in Kaposi's sarcoma
- B20-B24 Disease caused by human immunodeficiency virus [HIV]
- B17.1 Acute hepatitis C
- B16 Acute hepatitis B
- A84 Tick-borne viral encephalitis
- A63.0 Anogenital (venereal) warts
- Z29.1 Prophylactic immunotherapy
- Z54 Convalescence
- C57.9 Malignant neoplasm, female genital organ, unspecified
- B15-B19 Viral hepatitis